This site is intended for healthcare professionals

Go to /sign-in page

You can view 5 more pages before signing in

Go to /pro/cpd-dashboard page

This page is worth 0.05 CPD credits. CPD dashboard

Go to /account/subscription-details page

This page is worth 0.05 CPD credits. Upgrade to Pro

Clinical features

Authoring team

A prodrome of weight loss, malaise, low-grade fever, cough, and arthralgia with or without arthritis may be seen one to three weeks before the onset of the disease (1)

Characteristically the lesions are:

  • painful, palpable, dusky blue nodules or plaques:
    • may vary from 1-10 cm in diameter
    • poorly demarcated
    • most commonly on the shins and calves
    • may spread to the thighs and extensor surfaces of the forearm and the trunk
    • tend to be symmetrical
    • initially the nodules are firm but becomes more fluctuant as the disease progress
  • lesions resolve completely over 1-2 months and may produce to produce an appearance similar to bruising as they fade
  • ulceration of the nodules cannot be seen and usually heal without atrophy or scarring
  • there may be the appearance of new lesions as the old ones resolve

Arthralgia produced during the prodrome period has been known to continue for upto 2 years after the resolution of the disease and may cause nonspecific destructive changes in the joint (1).

Reference:


Create an account to add page annotations

Annotations allow you to add information to this page that would be handy to have on hand during a consultation. E.g. a website or number. This information will always show when you visit this page.

The content herein is provided for informational purposes and does not replace the need to apply professional clinical judgement when diagnosing or treating any medical condition. A licensed medical practitioner should be consulted for diagnosis and treatment of any and all medical conditions.

Connect

Copyright 2024 Oxbridge Solutions Limited, a subsidiary of OmniaMed Communications Limited. All rights reserved. Any distribution or duplication of the information contained herein is strictly prohibited. Oxbridge Solutions receives funding from advertising but maintains editorial independence.